Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleLetter: ustekinumab dose intensification for loss of response—should we re‐induce before shortening the dose interval? Author's reply.AuthorsKopylov, UriAbstractLINKED CONTENT This article is linked to Kopylov et al and Srinivansan papers. To view these articles, visit https://doi.org/10.1111/apt.15784 and https://doi.org/10.1111/apt.15883.SubjectsLETTERS; AUTHORSPublicationAlimentary Pharmacology & Therapeutics, 2020, Vol 52, Issue 3, p565ISSN0269-2813Publication typeArticleDOI10.1111/apt.15892